Skip to main content
Andrew Spitzer, MD, Orthopaedic Surgery, Los Angeles, CA, Cedars-Sinai Medical Center

AndrewIraSpitzerMD

Orthopaedic Surgery Los Angeles, CA

Hip & Knee Reconstructive Surgery

Director, Cedars-Sinai Joint Replacement Program

Dr. Spitzer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Spitzer's full profile

Already have an account?

Education & Training

  • Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical School
    Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolResidency, Orthopaedic Surgery, 1992 - 1993
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Orthopaedic Surgery, 1987 - 1992
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 1987

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1992 - 2024
  • MA State Medical License
    MA State Medical License 1992 - 2011
  • PA State Medical License
    PA State Medical License 1990 - 2008
  • American Board of Orthopaedic Surgery Orthopaedic Surgery

Awards, Honors, & Recognition

  • Top Doctors:LA Area Castle Connolly, 2013

Publications & Presentations

PubMed

Press Mentions

  • Flexion Therapeutics Announces Upcoming Presentations at the 2019 Osteoarthritis Research Society International (OARSI) World Congress
    Flexion Therapeutics Announces Upcoming Presentations at the 2019 Osteoarthritis Research Society International (OARSI) World CongressMay 2nd, 2019
  • Flexion Therapeutics Announces Publication of Data from Repeat Administration Trial of ZILRETTA® (Triamcinolone Acetonide Extended-Release Injectable Suspension) in Rheumatology and Therapy
    Flexion Therapeutics Announces Publication of Data from Repeat Administration Trial of ZILRETTA® (Triamcinolone Acetonide Extended-Release Injectable Suspension) in Rheumatology and TherapyFebruary 11th, 2019

Hospital Affiliations